GlassScriptPhysician profile
Alan G Anz
NPI 1366553323
$9,142.64
in general payments reported to CMS, 2019-2025
22 companies · $1,830 in 2025
The $1,830 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,449 · 2020: $625 · 2021: $53.93 · 2022: $72.46 · 2023: $31.69 · 2024: $1,081 · 2025: $1,830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366 · Travel and Lodging: $1,153 · Consulting Fee: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.99 |
| Travel and Lodging | $1,153.31 |
| Consulting Fee | $423.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,991.50 | 2019-2025 | Journey II, Real Intelligence, K-15 Pork |
| Zimmer Biomet Holdings, INC. | $1,326.97 | 2019-2025 | Oxford, Persona, Mymobility Platform |
| Hikma Pharmaceuticals USA | $423.20 | 2024 | Combogesic IV |
| Microport Orthopedics INC | $343.33 | 2024-2025 | Mpo Medial Pivot Knee |
| Medacta USA, INC. | $298.57 | 2025 | Gmk Sphere |
| Heraeus Medical, LLC. | $164.25 | 2024-2025 | |
| Pacira Therapeutics, INC. | $138.23 | 2019-2021 | |
| Depuy Synthes Sales INC. | $83.47 | 2019-2025 | Monovisc |
| Heron Therapeutics, INC. | $58.79 | 2021-2023 | Zynrelef |
| Stryker Corporation | $57.74 | 2020 | |
| Elite Orthopedics, LLC | $32.37 | 2024 | |
| Hospira, INC. | $31.98 | 2023-2024 | |
| Davol INC. | $30.54 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $25.51 | 2025 | |
| Kerecis Limited | $22.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $22.06 | 2025 | Hymovis |
| Bone Support INC. | $19.45 | 2022 | |
| Organogenesis INC. | $17.71 | 2021 | |
| Pfizer INC. | $15.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.07 | 2019 | |
| Medline Industries LP | $13.38 | 2022 | |
| Kci USA, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Anz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.